Please find attached disclosure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 3.4 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Riddhi Siddhi Gluco Biols Ltd received an order from the Securities Appellate Tribunal (SAT) on March 10, 2026, in its appeals against two SEBI orders from 2021. The appeal against the SEBI Adjudicating Officer's order (imposing a Rs. 5 lakh penalty each on the company and two promoter directors) was dismissed, and this penalty was already deposited earlier. The appeal against the SEBI Whole Time Member's order was partly allowed, with SAT reducing the period of debarment from the securities market. SAT upheld SEBI's findings on non-compliance with Minimum Public Shareholding (MPS) norms and allegations related to delisting. The company has been given 5 months to comply with MPS norms and is debarred from the securities market until compliance plus an additional 6 months. Promoters Ganpatraj Chowdhary, Siddharth Chowdhary, and CFO Mukesh Samdaria are debarred for 6 months from the order date.
The mixed SAT outcome provides partial relief through reduced debarment periods, but the company still faces a securities market ban until it achieves MPS compliance within 5 months. Shareholders should watch for the company's MPS compliance efforts and any further legal action, as failure to comply could extend the trading restrictions.